Eledon Pharmaceuticals, Inc. Share Price

Eledon Pharmaceuticals, Inc. Share Price

NASDAQ: ELDN | Micro Cap
$2.90
+$0.14 (5.06%) Last updated on 29 Oct, 2026 | 19:54 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Eledon Pharmaceuticals, Inc. Stock Performance

Open
$2.76
Prev. Close
$2.77
Circuit Range
N/A
Day Range
$2.75 - $2.90
Year Range
$1.37 - $4.51
Volume
33,241
Average Traded
$2.81

Eledon Pharmaceuticals, Inc. Share Price Today

As of 29 October 2026, Eledon Pharmaceuticals, Inc.'s share price is $2.90. The stock opened at $2.76, compared to its previous close of $2.77. During today's trading session, Eledon Pharmaceuticals, Inc.'s share price traded between $2.75 and $2.90, with an average price of $2.83. Over the past 52 weeks, the stock has recorded a high of $4.51 and a low of $1.37. In terms of performance, Eledon Pharmaceuticals, Inc.'s share price has declined by 19.97% over the last six months and is down 32.75% on a year-on-year basis.

Eledon Pharmaceuticals, Inc. Share Price Chart

Line chart of the Eledon Pharmaceuticals, Inc. price trend over the selected period. The price rose overall, ranging from 2.75 to 2.90, ending at 2.90.
$2.75$2.90
L
Show Current Price
H

Eledon Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators

Market Cap
$237.73M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.19
Revenue (TTM)
$0.00
Return On Equity (TTM)
-292.10%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-87.48%

Eledon Pharmaceuticals, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$16.13-$13.13-$36.94-$30.24
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A18.60%-181.34%18.14%

Eledon Pharmaceuticals, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$87.97-$116.54-$36.18-$45.62
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-32.48%68.95%-26.09%

About Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals Inc is a clinical stage biotechnology company using immunology expertise in targeting the CD40 Ligand pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis. Its compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40L, a well-validated biological target that has broad therapeutic potential. It operates as one reportable segment, focused on the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.

Eledon Pharmaceuticals, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$2.50
$2.85
+12.65%
Sep 2026
$2.94
$2.53
-23.80%
Aug 2026
$3.48
$3.32
-1.48%
Jul 2026
$4.00
$3.37
-14.25%
Jun 2026
$3.72
$3.93
+2.88%
May 2026
$3.62
$3.82
+5.23%
Apr 2026
$3.10
$3.63
+17.86%
Mar 2026
$2.57
$3.08
+17.78%
Feb 2026
$2.17
$2.62
+19.41%
Jan 2026
$1.52
$2.19
+45.51%
Dec 2025
$1.60
$1.50
-7.67%
Nov 2025
$4.50
$1.63
-62.27%

ELDN Share Price FAQs